Ropivacaine liposome injection (NAL Pharma)

罗哌卡因脂质体注射剂 (NAL Pharma)

Report date: 2025/07/21 11:43:27

Base Information

Drug NameRopivacaine liposome injection (NAL Pharma)
Drug Alias NameRopivacain Liposome 3-Day Injection (NAL Pharma)NAL-1278
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesNal Pharma LTD
China Registration ClassN/A

Develop Information

Active CompaniesNal Pharma LTD
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A